DrugMar 4, 2026
ADBRY recall — FDA D-0339-2026
Lack of Assurance of Sterility: due to the presence of particulate matter in one unit from the lot, which lab tests have identified as wool fiber.
Class IIFDA: OngoingLEO PHARMA INC
Recall history in this database
Classification mix: Class II: 2, Class III: 1.
DrugMar 15, 2017
Calcipotriene Cream 0.0005% recall — FDA D-0510-2017
Incorrect/Undeclared excipients: inadvertent omission of a drug excipient from the the Authorized Generic label and also a warning regarding contact dermatitis from the brand product…
Class IIFDA: TerminatedLEO PHARMA Inc.
DrugFeb 22, 2017
Taclonex recall — FDA D-0477-2017
Labeling: Incorrect or missing package insert: the affected product was packaged with an out-of-date package insert (PI) dated February 2014.
Class IIIFDA: TerminatedLEO PHARMA Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies LEO PHARMA Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.